The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora

Completed · Early Phase 1

Conditions studied: Epiphora

In brief

Prospective, open label, multi-center, non-randomized study designed to collect initial clinical data related to the safety and clinical performance of the Sinopsys Lacrimal Stent for use during repair of the lacrimal system in patients with functional or obstructive epiphora.

Key facts

Study ID

NCT02240615

Run by

Sinopsys Surgical

People needed

10

Starts

2014-10-01

Expected to finish

2016-02-01

Last updated by the study team

2016-02-12

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinically significant functional epiphora for at least three months
• Keros classification 1 or 2 skull base anatomy

You may not qualify if…

• Active infection
• Craniofacial deformity
• Severe inflammatory disease

Where it is running

• Stanford University — Stanford, California, United States
• University of Colorado Health Sciences Center — Aurora, Colorado, United States
• Center for Sight — Sarasota, Florida, United States
• Eye Care Specialists — Kingston, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.